Finance

Lists
Q2 2027 earnings • released • EPS beat +11.71% • Revenue beat +11.36%
See results
SAILIFE:NSE
Sai Life Sciences Ltd
₹1,836.00
+5.28%
(+92.00) 1D
Nov 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SAILIFE...
Open
₹1,738.80
High
₹1,897.30
Low
₹1,699.00
Mkt. cap
382.90B
Avg. vol.
888.32K
Volume
10.12M
P/E ratio
104.04
52-wk high
₹1,897.30
52-wk low
₹783.85
EPS
₹17.65
No. of employees
5K
Open
₹1,738.80
High
₹1,897.30
Low
₹1,699.00
Mkt. cap
382.90B
Avg. vol.
888.32K
Volume
10.12M
P/E ratio
104.04
52-wk high
₹1,897.30
52-wk low
₹783.85
EPS
₹17.65
No. of employees
5K
News stories
From web sources and news partners
Profile
Sai Life Sciences Limited is an Indian contract research, development, and manufacturing organisation, headquartered in Hyderabad, Telangana. The company provides drug discovery, development, contract manufacturing services for small-molecule new chemical entities to pharmaceutical and biotechnology companies. The company was established in Hyderabad in January 1999 as Sai Dru Syn Laboratories Limited. It was later renamed Sai Life Sciences Limited. It operates R&D and manufacturing facilities in India, the UK, and the USA. Wikipedia
About Sai Life Sciences Ltd
CEO-
Employees5.22K
Founded1999
Headquarters-
SectorHealth Care
Industry-
Websitesailife.com
Last report
Nov 6, 2026
Fiscal period
Q2 2027
₹4.58 / ₹4.10
+11.71%beat
Revenue / Est. (INR)
6.63B / 5.95B
+11.36%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.56B
6.02B
5.54B
6.63B
Cost of goods sold
1.28B
2.27B
1.45B
1.75B
Cost of revenue
1.28B
2.27B
1.45B
1.75B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.73B
1.96B
1.80B
1.98B
Operating expense
2.85B
2.43B
3.07B
3.46B
Total operating expenses
4.13B
4.70B
4.52B
5.20B
Operating income
1.44B
1.32B
1.02B
1.42B
Other non operating income
83.80M
-333.80M
35.43M
-
EBT including unusual items
1.34B
1.39B
979.74M
1.31B
EBT excluding unusual items
1.42B
1.39B
979.74M
1.31B
Income tax expense
337.91M
349.91M
246.89M
329.63M
Effective tax rate
25.19%
25.13%
25.20%
25.11%
Other operating expenses
676.72M
14.63M
814.72M
994.52M
Net income
1.00B
1.04B
732.85M
983.17M
Net profit margin
18.04%
17.31%
13.22%
14.84%
Earnings per share
5.00
4.86
3.42
4.58
Interest and investment income
-
186.18M
-
-
Interest expense
-96.99M
-78.25M
-76.36M
-109.41M
Net interest expenses
-96.99M
107.93M
-76.36M
-109.41M
Depreciation and amortization charges
440.75M
453.08M
459.37M
481.33M
EBITDA
1.66B
1.60B
1.44B
1.89B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps